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the age of 3 months. Generalized weakness 
(proximal more than distal) and muscular 
fasciculations were present. A neurogenic 
pattern in electromyography and micro-
scopically proved muscular atrophy (quad-
riceps femoris) supported a diagnosis of 
SMA. Nerve conduction velocity was nor-
mal as was the histology of a nerve biopsy 
specimen. Creatine kinase was moderately 
elevated (220 U/I). Molecular analysis 
showed a homozygous deletion in the SMN 
gene confirming the diagnosis of SMA. 
Additionally, the boy showed a bal-
anced translocation t(4q; IOq) (qter; q24.1) 
which is also present in his healthy mother. 
The father is healthy. The patient is the 
youngest in a sibship of four. A 9-year-old 
girl is healthy. The second child died at the 
age of 6 months from pneumonia in 
Kosovo. The third pregnancy ended in the 
second trimenon. The third child died at the 
age of 7 days with an unbalanced chromo-
somal aberration (partial trisomy 10, par-
tial monosomy 4) and is published 
elsewhere [4, case 2]. The SMN gene locus 
of the other children was not investigated. 
Considering the rarity of SMA (I: 10000 
to I :25000) its concurrence with the above 
balanced translocation may not be coinci-
dental. Assuming a causal relationship, 
there might be contributory factors on the 
chromosome regions 4qter or IOq24. 
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Sir: Central venous access is necessary to 
provide very-Iow-birth-weight (VLBW) in-
fants with sufficient amounts of fluids and 
calories. In order to reduce discomfort 
related to a peripheral transcutaneous in-
sertion method we evaluated a technique of 
insertion of the same small-diameter trans-
cutaneous silicone catheters (Nutricath 
"S", 0.3 mm inner and 0.6 mm outer 
diameter, 30 cm length, Code 2184, Vygon, 
France) through the umbilical vein, using a 
conventional polyurethane umbilical vein 
catheter (1.7 mm outer diameter, 38 cm 
length, Ref: 8888-160226 argyle, Sherwood 
Medical, Belgium) as an introducer. This 
technique has been introduced by Amato 
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et al. [I], who performed a similar study in 
1992. 
For the procedure both catheters are 
filled with 5% dextrose and inserted under 
strict sterile conditions at the bedside. After 
insertion the ubilical vein catheter is cut off 
at I cm above the umbilical stump and the 
small diameter catheter is then pushed 
forward through the lumen to a presumed 
central position and the polyurethane 
catheter withdrawn simultaneously. After 
fixation with small strips of adhesive sur-
gical tape (Steristrip 3 M, St. Paul, USA), 
the correct position of the catheter tip is 
radiographically verified using contrast 
media (0.5 ml of preheated Lopamiro 300, 
Bracco, Italy). 
Between 1990 and 1993 35 neonates 
with a mean birth weight of 1.114 
(650-1490) g and a mean gestational age of 
29.5 (27-34) weeks were provided with 
trans umbilical small-diameter silicone 
catheters at a mean age of 2.7 (1-5) days 
after deli very. All except one pa tien t re-
quired total or partial parenteral nutrition 
including fat emulsions due to prematurity 
and/or intolerance of gastro-intestinal 
feeding. They also received intravenous 
antibiotics. 
The trans umbilical venous catheters re-
mained in place for a total of 459 (2-45; 
mean 13). days In 5 patients (18%) the 
catheter had to be removed prematurely 
due to complications, such as leakage and 
extravasation of contrast fluid in the sub-
diaphragmal area suggesting perforation, 
transitory colour change on the left gluteal 
region after dislocation, lack of drainage 
without proven thombosis, and leakage of 
the catheter, in one case each. Apart from 
these one lethal complication occurred. A 
catheter initially falsely positioned in the 
right atrium, perforated into the peri-
cardium, causing cardiac tamponade. 
Bacterial growth at the catheter tip at 
removal was found in 6 of 17 (26%) 
examined cases, coagulase-negative 
Staphylococci (4), Enterobacter (1) and 
Candida albicans (I) being isolated. 
According to our very limited experi-
ence, this simple and painless technique 
seems to be a promising alternative to 
provide critically ill VLBW infants with a 
central venous access necessary for nutri-
tional support and intravenous therapies. 
The incidence of complications and the 
frequency of bacterial growth at the cath-
eter tip at removal are comparable to those 
found in series of percutaneously inserted 
small-diameter silas tic catheters [1, 2]. De-
spite frequent isolation of pathogens at the 
catheter tips large series report catheter-
related septicaemias to occur in only 1.9%-
11 % [1-3]. In our series one infant was 
clinically suspected to have a catheter-
related infection, but no pathogen could be 
isolated from peripheral blood. 
In conclusion our results are similar to 
those of Amato et al. [1] and seem to be 
comparable with those obtained in large 
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series of conventionally inserted percuta-
neous small-diameter silas tic venous cathe-
ters in neonates [1-6]. However, further and 
larger prospective studies are needed to 
validate our data. 
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Macroscopic haematuria 
following immunisation 
with tetanus toxoid and oral 
polio vaccine 
Sir: Haematuria is not a recognised com-
plication of immunisation with either teta-
nus toxoid or oral polio vaccines. We report 
a case of macroscopic haematuria following 
such immunisation. 
The patient was a 15-year-old boy who 
was physically well and, in the past, had 
received routine immunisations with no 
adverse reactions noted. There was no past 
history or family history of renal disease 
and no history of recent throat, skin or 
other infection. Twenty-four hours follow-
ing immunisation with tetanus toxoid and 
oral polio vaccines, he became unwell with 
headache and abdominal pain. Local 
swelling, erythema and tenderness devel-
oped around the site of the tetanus immu-
nisation. Twenty-four hours later, he 
developed macroscopic haematuria and 
was admitted to hospital. General exami-
nation was unremarkable; blood pressure 
was normal. Urine microscopy confirmed 
haematuria. Subsequent investigations in-
cluded urine culture, full blood count, 
serum electrolytes and creatinine, serum 
complement C3 and C4 , immunoglobulins, 
plain abdominal X-ray, ultrasound scan 
and urinary calcium/creatinine ratio. The 
results of all of these investigations were 
normal. The haematuria spontaneously re-
solved and there has been no recurrence. 
The episode of haematuria was tempo-
rally related to immunisation, and prior to 
this, there were symptoms suggesting a 
generalised reaction to one of the vaccines. 
It is therefore probable that the haematuria 
occurred as a direct result of immunisation. 
On enquiry to the U.K . Medicines Control 
Agency, we learnt that there had been five 
previous unpublished cases of haematuria 
associated with tetanus immunisation re-
ported to them (personal communication). 
In these cases, the onset of haematuria 
occurred up to 4 days following immuni-
sation in a group ranging in age from 5 
months to 65 years. The long-term outcome 
in this group is unknown. There has been 
only one previous report of haematuria 
related to administration of oral polio 
vaccine. It is clearly important that any 
similar cases should be reported. 
This child was appropriately investi-
gated to exclude common causes of ha-
ematuria. In this case renal biopsy was not 
indicated but it is important to recognise 
that this child may still have an underlying 
renal disorder, despite the absence of a past 
history or family history. Given the appar-
ent infrequent association between ha-
ematuria and immunisation, we would 
suggest that all similar cases still need to be 
fully investigated and followed up to ex-
clude other more common and significant 
causes of haematuria. 
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